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Abstract 
Haemophilus parasuis is an early colonizer of the porcine upper respiratory tract and is the etiological agent of 
Glasser’s disease. The factors responsible for H. parasuis colonization and systemic infection are not yet well under-
stood, while prevention and control of Glasser’s disease continues to be challenging. Recent studies on innate immu-
nity to H. parasuis have demonstrated that porcine alveolar macrophages (PAMs) are able to differentially up-regulate 
several genes related to inflammation and phagocytosis, and several pro-inflammatory cytokines are produced by 
porcine cells upon exposure to H. parasuis. The susceptibility of H. parasuis strains to phagocytosis by PAMs and the 
bactericidal effect of complement are influenced by the virulent phenotype of the strains. While non-virulent strains 
are susceptible to phagocytosis and complement, virulent strains are resistant to both. However, in the presence of 
specific antibodies against H. parasuis, virulent strains become susceptible to phagocytosis. More information is still 
needed, though, in order to better understand the host immune responses to H. parasuis. Antimicrobials are com-
monly used in the swine industry to help treat and control Glasser’s disease. Some of the common antimicrobials 
have been shown to reduce colonization by H. parasuis, which may have implications for disease dynamics, devel-
opment of effective immune responses and immunomodulation. Here, we provide the current state of research on 
innate and adaptive immune responses to H. parasuis and discuss the potential effect of enrofloxacin on the develop-
ment of a protective immune response against H. parasuis infection.
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swine-rearing countries and remains a significant patho-
gen in contemporary swine production systems [1]. In 
addition to causing disease, H. parasuis is frequently iso-
lated from the upper respiratory tract of healthy pigs [2, 
3]. Multiple different genotypes and serotypes of H. par-
asuis have been described. However, there is not a clear 
association between virulence and H. parasuis pheno-
types or genotypes [4]. Successful vaccination resulting 
in decreased mortality has been achieved by bacterins 
and autogenous vaccines, but failures are frequent due to 
poor cross-protection [5–8]. The ability of H. parasuis to 
interact with the swine host, causing or not disease, is a 
subject that needs further investigation. Recently, reverse 
vaccinology and immunoproteomic analysis identified 
several putative virulence-associated genes and immu-
nogenic proteins in different H. parasuis strains [9–12]. 
Follow-up vaccine studies in mice and piglets using 
recombinant antigens revealed strong seroconversion, 
but only partial protection against homologous challenge 
and weak or inexistent cross-protection [13, 14].
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1 Introduction
Haemophilus parasuis is one of the most important bac-
teria affecting pigs. The disease caused by this patho-
gen is characterized by polyserositis and it is known as 
Glasser’s disease [1]. H. parasuis is present in all major 
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Because of the incomplete efficacy of vaccines, anti-
microbials are needed to treat H. parasuis infections [1]. 
Pigs receiving antimicrobials early during infection with 
H. parasuis are usually able to survive a systemic infec-
tion [1]. More specifically, enrofloxacin is a fluoroqui-
nolone active against Gram-negative and Gram-positive 
bacteria [15]. Enrofloxacin inhibits the bacterial DNA 
gyrase (a type II topoisomerase), preventing DNA super-
coiling and replication, which leads to cell death [16]. 
Additionally, enrofloxacin has been shown to temporarily 
decrease the load of H. parasuis naturally colonizing the 
upper respiratory tract of conventional pigs [3].
Even though there is not a standard method for evaluat-
ing the antimicrobial susceptibility against H. parasuis [17], 
some studies that included Spanish [18] and Chinese [19] 
strains have shown antimicrobial resistance to enrofloxacin 
using breakpoints recommended by the Clinical and Labo-
ratory Standard Institute (CLSI) for other bacterial species. 
Although many H. parasuis strains are considered suscep-
tible to enrofloxacin, it is important to emphasize the judi-
cious use of antimicrobials to treat Glasser’s disease and 
to monitor susceptibility patterns of H. parasuis isolates 
before administration of a given therapy.
Enrofloxacin has also been shown to hinder immunity to 
several bacterial species, including Actinobacillus pleuro-
pneumoniae in swine [20]. Moreover, early elimination of 
various bacterial pathogens by antimicrobials hindered the 
development of protective immune responses necessary to 
overcome future infections [21–23]. While it is clear that 
the use of antimicrobials exert a direct deleterious effect 
over bacterial infections, recent findings described below 
are shedding light on their potential effect on immune 
responses. However, the interaction between antimicro-
bials and immune responses to H. parasuis is not known. 
The purpose of the present review is to summarize exist-
ing knowledge concerning the swine immune response to 
H. parasuis and we discuss the potential mechanisms for 
interaction between enrofloxacin and immunity.
2  Protective immunity against H. parasuis
There has been a great expansion on knowledge in 
regards to the pig immune system and its effect in dis-
ease and protective immunity against infections. Pigs 
can respond almost immediately to an infectious agent 
through innate immune mechanisms, which might con-
trol the infection until activation of the adaptive immune 
system [23]. Shortly after infection, bacteria encoun-
ters the innate immune system, which is activated when 
pattern-recognition receptors (PRRs), including toll-like 
receptors (TLRs), contact pathogen-associated molecular 
patterns (PAMPs) and induce different signaling path-
ways [24]. Bacterial invasion also triggers the comple-
ment system [25], induces migration of phagocytic cells 
and the production of various cytokines, which provides 
antimicrobial defense, recruit of more cells through the 
inflammatory process and assists in the activation of 
acquired immunity [23].
The activation of the acquired immune response results 
in additional cytokine production, T-cell and B-cell acti-
vation, and antibody production. The acquired immune 
response also provides the host with specific memory for 
protection against subsequent homologous infections 
[23]. Specific reagents, improved technology and more 
detailed knowledge of the porcine immune cell popula-
tions now enable detailed analyses of the antigen-specific 
immune responses in swine [26–29]. Although protective 
immunity against extracellular bacteria is largely depend-
ent on antibodies, cellular responses are often required 
for full expression of immunity [23].
2.1  Innate defense mechanisms to H. parasuis
Porcine alveolar macrophages (PAMs) are considered an 
important line of defense against H. parasuis infection 
[30]. PAMs isolated from pigs inoculated with H. par-
asuis were able to differentially up-regulate several genes 
related to cytokine production, phagocytosis, formation 
of phagolysosome, signal transduction and nitric oxide 
production [31].
In vitro studies have demonstrated that non-virulent 
strains are susceptible to phagocytosis by PAMs, while 
virulent H. parasuis strains are resistant [30]. Differently 
from the mechanism of phagocytosis for non-virulent 
strains, phagocytosis of virulent strains is not dependent 
on actin filaments [30]. In addition, competition assays 
have shown that phagocytosis of H. parasuis is probably 
not dependent on a specific receptor, since phagocytosis 
of non-virulent strains was not affected by the presence 
of non-virulent or virulent strains [30].
Moreover, in  vivo studies have shown that there is a 
delay in the processing of virulent H. parasuis strains 
by PAMs and a 24 h delay in macrophage activation by 
H. parasuis virulent strains when compared to non-vir-
ulent strains [32]. While there is no difference on asso-
ciation of virulent and non-virulent strains with early 
endosomes, non-virulent strains were found more fre-
quently associated with mature endosomes than virulent 
strains after one-hour incubation [33]. This inhibition 
of early host responses to virulent H. parasuis may lead 
to the development of Glasser’s disease [32]. Interfer-
ence of phagocytosis by H. parasuis virulent strains is 
likely associated with presence of capsule [30]. Addition-
ally, two virulent-associated trimeric autotransporter 
(VtaA) antigens, VtaA 8 and VtaA 9, identified in the 
H. parasuis outer membrane, delayed interactions with 
macrophages, even though they did not prevent phago-
cytosis [33].
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Immunohistochemistry and immunoperoxidase tech-
niques have also demonstrated that following systemic 
infection, H. parasuis antigens were found as degener-
ated bacteria in dilated phagosomes in serosal lesions 
[34, 35]. Apparently, late leukocyte responses that are 
activated after infection with virulent strains are able to 
efficiently phagocytize H. parasuis, which is in agreement 
with in vitro studies that have shown that virulent H. par-
asuis strains do not survive inside macrophages when 
internalized [30].
Cytokines participating in the inflammatory response 
to H. parasuis including interleukin (IL)-8 and IL-6, were 
produced by porcine tracheal and endothelial cells upon 
contact with H. parasuis [36, 37]. Acute phase response 
stimulated by IL-6 production and chemoattraction of 
leukocytes stimulated by IL-8 represent essential roles of 
these cytokines in inflammatory response to H. parasuis 
[36]. Furthermore, increased IL-1α expression in lung has 
been reported in pigs undergoing severe Glasser’s disease 
following experimental infection, whereas IL-4, IL-10, 
tumor necrosis factor (TNF)-α, and interferon (IFN)-γ 
were expressed in significantly higher levels in spleen, 
pharyngeal lymph nodes, lung and brain of survivors 
[38]. Similarly, in vivo studies with pigs challenged with 
highly virulent H. parasuis showed an increase propor-
tion of CD163+ monocytes, which are able to produce 
high amounts of proinflammatory cytokines, such as 
TNF-α, IL-1 and IL-6 [39].
As part of another line of defense of the innate immune 
response, γδ T-cells were found in reduced numbers in 
pigs after challenge with a lethal dose of a highly virulent 
H. parasuis strain [39]. γδ T-cells represent a numer-
ous lymphocyte subset population in pigs able to recog-
nize unprocessed non-peptide antigens [26]. These cells 
can cause cytotoxicity and produce T helper (Th)-1 and 
Th-2 cytokines that contribute to inflammatory and anti-
inflammatory immune response [31]. A reduction on 
γδ T-cells might render the pigs more susceptible to H. 
parasuis infection, suggesting that this could be one of 
the mechanisms of pathogenesis of H. parasuis virulent 
strains even though such mechanism still needs to be elu-
cidated [39].
Antibody-independent activation of the complement 
cascade is an initial host’s defense mechanism, caus-
ing vasodilatation and increased vascular permeabil-
ity resulting in attraction of phagocytic cells to the site 
of infection [23]. The complement cascade also results 
in the formation of a complex of proteins that acts as 
a pore in the bacterial wall ultimately causing bacte-
rial lysis. The activation of complement can be made by 
bacterial endotoxins such as lipopolysaccharides (LPS), 
peptidoglycan and teichoic acids [23]. Non-virulent H. 
parasuis strains were susceptible to complement in an 
antibody-independent way, while virulent strains evade 
this host response and resist to complement-mediated 
killing [40]. Therefore, resistance to antibody-independ-
ent complement killing seems to be a mechanism of 
pathogenicity of H. parasuis virulent strains [40] and it 
was demonstrated that the H. parasuis outer membrane 
protein P2 (OmpP2) is required for serum resistance 
[41].
2.2  Acquired defense mechanisms against H. parasuis
While the porcine innate immune system confers ini-
tial protection, the acquired immune system provides a 
second, more specific and long lasting, line of defense 
against infectious organisms [25]. According to stud-
ies performed in mice, following antigen stimulation, Th 
cells differentiate into Th-1 or Th-2 cells. The functions 
of Th-1 and Th-2 cells correlate with the production of 
their cytokines. Th-1 cells are involved in cell-mediated 
inflammatory functions through secretion of IL-2 and 
IFN-γ. Th-2 cells encourage antibody production, and 
also enhance eosinophil proliferation and function by 
secreting IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13 [42]. 
Accordingly, Th-2 cytokines are commonly found in 
association with antibody responses [42], even though 
in pigs the Th-2 cytokine, IL-4, was not able to stimulate 
porcine B-cell and antibody production in vitro [43].
Significant rises in the total proportion of Th-1 and 
Th-2 (CD4+) cells were observed in all pigs that sur-
vived challenge with live H. parasuis, while susceptible 
pigs showed a decrease of CD4+ T cells [44]. Cytotoxic 
(CD8+) T cells and B-cells were significantly increased 
in all pigs between 1 and 3 days after challenge, indepen-
dently of survival [39]. Further studies are needed to elu-
cidate cellular immune responses to H. parasuis infection 
that are related to protection.
A humoral immune response is usually activated when 
pigs are infected with H. parasuis [35]. Such response is 
frequently associated with the development of a tran-
sient IgM response followed by a solid and progressively 
increasing IgG antibody response [45]. Moreover, pas-
sive immunization of pigs with serum containing specific 
antibodies against H. parasuis confirmed the role of the 
humoral response on protection against lethal challenge 
[46]. The mechanism of protection by antibodies seems 
to be due to the role of antibodies in opsonization of H. 
parasuis strains to facilitate phagocytosis [30]. In particu-
lar, virulent H. parasuis strains require prior opsoniza-
tion with specific antibodies in order to be phagocytosed 
by PAMs and, if internalized, they are successfully killed 
by PAMs [30].
In comparison with the amount of information avail-
able on the immune response to H. parasuis systemic 
infection, knowledge on immune response to H. parasuis 
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colonization is limited, even though H. parasuis is a com-
mon colonizer of pigs. It has been demonstrated that 
non-virulent H. parasuis strains possess mechanisms of 
immune evasion, such as biofilm formation [47]. Bio-
film formation might protect bacteria from the attack 
of the host immune response and facilitate colonization 
of the upper respiratory tract by non-virulent strains. In 
addition, non-virulent strains are usually susceptible to 
phagocytosis by PAMs [30] and sensitive to the bacteri-
cidal effects of serum [48], which might prevent bacteria 
from surviving in the lungs and invading systemically the 
hosts. In addition, an increase in H. parasuis colonization 
rate was associated with a decrease in H. parasuis serum 
antibodies [2]. Therefore, serum antibodies in piglets 
might be able to modulate the timing and level of coloni-
zation by H. parasuis, and be relevant to avoid systemic 
disease caused by H. parasuis [2].
3  Effects of enrofloxacin on the immune response
Most of the findings reporting the interactions of antimi-
crobials with the immune system were discovered using 
mouse models [21, 22]. These findings contribute to the 
understanding of how the use of antimicrobial drugs 
can interfere with protection against a specific bacterial 
infection, either by interacting with the cellular and/or 
humoral immune response or by decreasing the antigen 
responsible for triggering an immune response. However, 
the mechanisms by which they act still need to be further 
investigated, especially for large animals.
Enrofloxacin, a fluoroquinolone, is actively accumu-
lated in phagocytes, but it did not interfere with the 
chemotaxic action of porcine polymorphonuclear leuko-
cytes (PMNs) or phagocytosis of A. pleuropneumoniae, 
Pasteurella multocida and Staphylococcus aureus by 
PMNs and PAMs when compared to untreated controls 
[49]. However, the intraphagocytic killing of A. pleuro-
pneumoniae was significantly enhanced by enrofloxacin 
in both PMNs and PAMs [49]. More research is needed, 
though, to investigate whether these effects would also 
apply to H. parasuis.
In swine, a protective humoral immune response to 
A. pleuropneumoniae was impeded by treatment with 
enrofloxacin but not by treatment with penicillin or tet-
racycline [20]. Absence of seroconversion might have 
been related to the high efficiency of enrofloxacin in 
eliminating the inoculated A. pleuropneumoniae quickly 
enough to prevent the activation of an acquired immune 
response. Regarding H. parasuis, even though there is no 
specific information available on antimicrobial interfer-
ence on the immune response, it is known that enrofloxa-
cin is able to reduce the load of H. parasuis in the upper 
respiratory tract of naturally colonized pigs [3]. Interfer-
ence with H. parasuis colonization might be associated 
with interference with the development of a protec-
tive immune response to colonizing bacteria, since pigs 
experimentally inoculated with a low dose of virulent H. 
parasuis strain were less susceptible to Glasser’s disease 
in the field [50, 51].
4  Conclusions
Protection against H. parasuis disease involves the acti-
vation of several elements of the innate and acquired por-
cine immune system, most of which are still unknown. 
Specific H. parasuis virulent factors allow this bacte-
rium to evade the innate immune system and invade 
systemic tissues, causing severe inflammation of sero-
sas by cytokine activation and attraction of phagocytes. 
A serum antibody response is usually present in pigs 
surviving systemic infection or after vaccination and is 
highly associated with protection against H. parasuis 
disease, even though heterologous protection is limited. 
Since antimicrobial use is widespread in the swine indus-
try and antimicrobials are used as an option to control H. 
parasuis disease, their effects on the immune response 
need to be taken into account. While antibiotic treatment 
can be very effective at controlling H. parasuis infections, 
it may also interfere with the development of protec-
tive immune responses against H. parasuis. Therefore, 
an improved understanding of how H. parasuis primes 
a protective immune response and the specific roles of 
humoral and cellular immune responses in protection 
to H. parasuis disease are needed. An improved under-
standing on the effect of antimicrobials on the immune 
response will contribute to the development of better 
control programs for H. parasuis and will help develop 
judicious antibiotic treatment practices.
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